NEW YORK, July 11 – Ventana Medical Systems and BD Biosciences Clontech Laboratories have agreed to non-exclusively co-market their microarray products, the companies said Wednesday.

Together, the two companies will co-promote BD Biosciences’ DNA microarrays, and Ventana’s microarray analysis platform. Financial details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.